Edimer Pharmaceuticals Receives New Financing

  • Feed Type
  • Date
  • Company Name
    Edimer Pharmaceuticals
  • Mailing Address
    29 Newbury Street Boston, MA 02116
  • Company Description
    The company provides pharmaceutical products and services.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Third Rock Ventures

Trending on Xconomy

By posting a comment, you agree to our terms and conditions.

2 responses to “Edimer Pharmaceuticals Receives New Financing”

  1. Janine Varcoe says:

    Hi, my name is Janine Varcoe from Australia. I have been doing some research on XLHED as my daughter has been diagnosed with this over a year ago. I’m not sure if this is the correct channel to go through as I wanted to register my details on the patient registry. I am interested to learn more about the studies and development of a recombinant protein. Can you please tell me where to register. I have been told by specialists in Australia that my daughter has a rare case of XLHED – in so far as that she is female, and normally males are the ones that have Ectodermal Dysplasia to the degree that she does. Please don’t hesitate to contact me should you require further details. Thank you in advance for your assistance. Janine.

  2. Olivier Gaide says:

    Dear Janine,

    The patient registry is an incentive of the NFED and you should refer to their website (www.nfed.org), it should soon be there. Their website is a mine of information on ED (including HED) and you should find answers to some of your questions there. Are you also aware that there is an australian association (http://www.ozed.org.au/)?

    Best regards,